-
Something wrong with this record ?
Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications
Y. Dauvilliers, K. Šonka, RK. Bogan, M. Partinen, R. Del Rio Villegas, N. Foldvary-Schaefer, R. Skowronski, A. Chen, J. Black, F. Skobieranda, MJ. Thorpy
Language English Country New Zealand
Document type Published Erratum
NLK
ProQuest Central
from 2008-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2008-01-01 to 1 year ago
Psychology Database (ProQuest)
from 2008-01-01 to 1 year ago
- Publication type
- Published Erratum MeSH
Albert Einstein College of Medicine Bronx NY USA
Department of Clinical Neurosciences University of Helsinki Helsinki Finland
Helsinki Sleep Clinic Terveystalo Healthcare Helsinki Finland
Jazz Pharmaceuticals Palo Alto CA USA
Jazz Pharmaceuticals Philadelphia PA USA
Neurophysiology and Sleep Disorders Unit Vithas Hospitals Madrid Spain
Sleep Disorders Center Cleveland Clinic Cleveland OH USA
Stanford University Center for Sleep Science and Medicine Redwood City CA USA
University of Montpellier INSERM Institute Neuroscience Montpellier Montpellier France
University of South Carolina School of Medicine Columbia SC USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22016923
- 003
- CZ-PrNML
- 005
- 20220720100035.0
- 007
- ta
- 008
- 220718s2022 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s40263-022-00933-1 $2 doi
- 035 __
- $a (PubMed)35764867
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Dauvilliers, Yves $u Sleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, 80 Avenue Augustin Fliche, 34295, Montpellier, France. y-dauvilliers@chu-montpellier.fr $u University of Montpellier, INSERM Institute Neuroscience Montpellier (INM), Montpellier, France. y-dauvilliers@chu-montpellier.fr $1 https://orcid.org/0000000306836506
- 245 10
- $a Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications / $c Y. Dauvilliers, K. Šonka, RK. Bogan, M. Partinen, R. Del Rio Villegas, N. Foldvary-Schaefer, R. Skowronski, A. Chen, J. Black, F. Skobieranda, MJ. Thorpy
- 655 _2
- $a tisková chyba $7 D016425
- 700 1_
- $a Šonka, Karel $u Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Bogan, Richard K $u University of South Carolina School of Medicine, Columbia, SC, USA
- 700 1_
- $a Partinen, Markku $u Helsinki Sleep Clinic, Terveystalo Healthcare, Helsinki, Finland $u Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland
- 700 1_
- $a Del Rio Villegas, Rafael $u Neurophysiology and Sleep Disorders Unit, Vithas Hospitals, Madrid, Spain
- 700 1_
- $a Foldvary-Schaefer, Nancy $u Sleep Disorders Center, Cleveland Clinic, Cleveland, OH, USA
- 700 1_
- $a Skowronski, Roman $u Jazz Pharmaceuticals, Palo Alto, CA, USA
- 700 1_
- $a Chen, Abby $u Jazz Pharmaceuticals, Palo Alto, CA, USA
- 700 1_
- $a Black, Jed $u Jazz Pharmaceuticals, Palo Alto, CA, USA $u Stanford University Center for Sleep Science and Medicine, Redwood City, CA, USA
- 700 1_
- $a Skobieranda, Franck $u Jazz Pharmaceuticals, Philadelphia, PA, USA
- 700 1_
- $a Thorpy, Michael J $u Albert Einstein College of Medicine, Bronx, NY, USA
- 773 0_
- $w MED00001186 $t CNS drugs $x 1179-1934 $g Roč. 36, č. 7 (2022), s. 785-786
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35764867 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100030 $b ABA008
- 999 __
- $a ind $b bmc $g 1816371 $s 1168165
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 36 $c 7 $d 785-786 $e - $i 1179-1934 $m CNS drugs $n CNS Drugs $x MED00001186
- LZP __
- $a Pubmed-20220718
